vs
Side-by-side financial comparison of PARK NATIONAL CORP (PRK) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PARK NATIONAL CORP is the larger business by last-quarter revenue ($168.3M vs $164.7M, roughly 1.0× PTC THERAPEUTICS, INC.). PARK NATIONAL CORP runs the higher net margin — 25.3% vs -82.0%, a 107.3% gap on every dollar of revenue. On growth, PARK NATIONAL CORP posted the faster year-over-year revenue change (2.2% vs -22.7%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $-36.6M). Over the past eight quarters, PARK NATIONAL CORP's revenue compounded faster (4.9% CAGR vs -11.5%).
National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
PRK vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.3M | $164.7M |
| Net Profit | $42.6M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | — | -43.3% |
| Net Margin | 25.3% | -82.0% |
| Revenue YoY | 2.2% | -22.7% |
| Net Profit YoY | 10.4% | -104.8% |
| EPS (diluted) | $2.62 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.3M | $164.7M | ||
| Q3 25 | $169.5M | $211.0M | ||
| Q2 25 | $168.7M | $178.9M | ||
| Q1 25 | $157.9M | $1.2B | ||
| Q4 24 | $164.7M | $213.2M | ||
| Q3 24 | $170.3M | $196.8M | ||
| Q2 24 | $157.7M | $186.7M | ||
| Q1 24 | $152.8M | $210.1M |
| Q4 25 | $42.6M | $-135.0M | ||
| Q3 25 | $47.2M | $15.9M | ||
| Q2 25 | $48.1M | $-64.8M | ||
| Q1 25 | $42.2M | $866.6M | ||
| Q4 24 | $38.6M | $-65.9M | ||
| Q3 24 | $38.2M | $-106.7M | ||
| Q2 24 | $39.4M | $-99.2M | ||
| Q1 24 | $35.2M | $-91.6M |
| Q4 25 | — | -43.3% | ||
| Q3 25 | 34.3% | 1.4% | ||
| Q2 25 | 35.2% | -19.5% | ||
| Q1 25 | 32.4% | 82.5% | ||
| Q4 24 | — | -76.2% | ||
| Q3 24 | 27.4% | -27.7% | ||
| Q2 24 | 30.6% | -21.5% | ||
| Q1 24 | 27.8% | -21.6% |
| Q4 25 | 25.3% | -82.0% | ||
| Q3 25 | 27.8% | 7.5% | ||
| Q2 25 | 28.5% | -36.3% | ||
| Q1 25 | 26.7% | 73.7% | ||
| Q4 24 | 23.5% | -30.9% | ||
| Q3 24 | 22.4% | -54.2% | ||
| Q2 24 | 25.0% | -53.1% | ||
| Q1 24 | 23.0% | -43.6% |
| Q4 25 | $2.62 | $-1.63 | ||
| Q3 25 | $2.92 | $0.20 | ||
| Q2 25 | $2.97 | $-0.83 | ||
| Q1 25 | $2.60 | $10.04 | ||
| Q4 24 | $2.38 | $-0.85 | ||
| Q3 24 | $2.35 | $-1.39 | ||
| Q2 24 | $2.42 | $-1.29 | ||
| Q1 24 | $2.17 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $233.5M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $-205.3M |
| Total Assets | $9.8B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $233.5M | $1.9B | ||
| Q3 25 | $218.9M | $1.7B | ||
| Q2 25 | $193.1M | $2.0B | ||
| Q1 25 | $237.6M | $2.0B | ||
| Q4 24 | $160.6M | $1.1B | ||
| Q3 24 | $201.7M | $1.0B | ||
| Q2 24 | $261.5M | $1.1B | ||
| Q1 24 | $306.1M | $884.8M |
| Q4 25 | $1.4B | $-205.3M | ||
| Q3 25 | $1.3B | $-155.8M | ||
| Q2 25 | $1.3B | $-206.5M | ||
| Q1 25 | $1.3B | $-185.8M | ||
| Q4 24 | $1.2B | $-1.1B | ||
| Q3 24 | $1.2B | $-1.1B | ||
| Q2 24 | $1.2B | $-980.2M | ||
| Q1 24 | $1.2B | $-893.9M |
| Q4 25 | $9.8B | $2.9B | ||
| Q3 25 | $9.9B | $2.6B | ||
| Q2 25 | $9.9B | $2.6B | ||
| Q1 25 | $9.9B | $2.7B | ||
| Q4 24 | $9.8B | $1.7B | ||
| Q3 24 | $9.9B | $1.8B | ||
| Q2 24 | $9.9B | $1.9B | ||
| Q1 24 | $9.9B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $198.3M | $-34.3M |
| Free Cash FlowOCF − Capex | $191.9M | $-36.6M |
| FCF MarginFCF / Revenue | 114.1% | -22.3% |
| Capex IntensityCapex / Revenue | 3.8% | 1.4% |
| Cash ConversionOCF / Net Profit | 4.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $328.2M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $198.3M | $-34.3M | ||
| Q3 25 | $52.6M | $-66.3M | ||
| Q2 25 | $49.7M | $-58.3M | ||
| Q1 25 | $37.9M | $870.1M | ||
| Q4 24 | $178.8M | $-30.0M | ||
| Q3 24 | $43.8M | $-77.0M | ||
| Q2 24 | $50.9M | $-71.5M | ||
| Q1 24 | $35.0M | $70.8M |
| Q4 25 | $191.9M | $-36.6M | ||
| Q3 25 | $51.1M | $-69.7M | ||
| Q2 25 | $48.4M | $-59.6M | ||
| Q1 25 | $36.8M | $868.4M | ||
| Q4 24 | $169.7M | $-33.8M | ||
| Q3 24 | $41.7M | $-77.5M | ||
| Q2 24 | $49.0M | $-78.8M | ||
| Q1 24 | $31.9M | $61.2M |
| Q4 25 | 114.1% | -22.3% | ||
| Q3 25 | 30.1% | -33.1% | ||
| Q2 25 | 28.7% | -33.3% | ||
| Q1 25 | 23.3% | 73.8% | ||
| Q4 24 | 103.0% | -15.8% | ||
| Q3 24 | 24.5% | -39.4% | ||
| Q2 24 | 31.1% | -42.2% | ||
| Q1 24 | 20.8% | 29.1% |
| Q4 25 | 3.8% | 1.4% | ||
| Q3 25 | 0.9% | 1.6% | ||
| Q2 25 | 0.8% | 0.7% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 5.6% | 1.8% | ||
| Q3 24 | 1.2% | 0.3% | ||
| Q2 24 | 1.2% | 4.0% | ||
| Q1 24 | 2.1% | 4.6% |
| Q4 25 | 4.65× | — | ||
| Q3 25 | 1.11× | -4.17× | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 0.90× | 1.00× | ||
| Q4 24 | 4.63× | — | ||
| Q3 24 | 1.14× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | 0.99× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
